Conclusion
The present meta-analysis has shown that it is an entirely effective non-invasive treatment for uterine fibroids; this is evident by reducing the overall NPV, tSSS% change, and decrease in the fibroid size. The studies focussing on the impact of HrQoL are needed in this aspect. The trials focusing on the reproductive outcomes should focus on the recommendation of this therapy for uterine fibroids.
Acknowledgment: None Declared.
Statement of Ethics: All procedures performed in the study were in accordance with the institutional and/or national research committee’s standards and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of Interest Statement: The authors declare that they have no competing interests.
Funding Sources: No Funding was received.
Author Contributions: SZ and YR: Concept and designed the study, HZ and XZ: analyzed data and drafting of the manuscript; XL and YW: Collected the data and helped in data analysis; MZ: Proofreading and final editing along with guarantor of the manuscript.
“All authors read and approved the final version of the manuscript”.